There was no significant difference in the overall survival time according to OPN expression in the early-stage (FIGO IA1-IIA2), advanced-stage (FIGO IIB-IVB) cohort or adenocarcinoma patients (Supplementary Figure S1B). Here, SPP1 is linked to adenocarcinoma.